Výsledky vyhledávání - "C. Askov-Hansen"

The use of metabolic balance studies in the objective discrimination between intestinal insufficiency and intestinal failure

Autor: August P. Prahm, Palle Jeppesen, C. Askov-Hansen, Christopher F. Brandt, Per Brøbech Mortensen

Publikováno v: The American journal of clinical nutrition. 106(3)

Background: In research settings that use metabolic balance studies (MBSs) of stable adult patients with short bowel syndrome, intestinal failure (IF) and dependence on parenteral support (PS) have been defined objectively as energy absorption

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54fc00ce5c3f44cb499bf853c82b7e49
https://pubmed.ncbi.nlm.nih.gov/28768655

Zobrazit plný text záznamu

A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients

Autor: Palle Jeppesen, Jens J. Holst, P. B. Mortensen, Bolette Hartmann, Rahim M. Naimi, C. Askov-Hansen, Christopher F. Brandt, K.B. Madsen

Publikováno v: Regulatory Peptides. 184:47-53

Objective Glucagon-like peptide 2 (GLP-2), secreted endogenously from L-cells in the distal bowel in relation to meals, modulates intestinal absorption by adjusting gastric emptying and secretion and intestinal growth. Short bowel syndrome (SBS) pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f53deb8b65be64245ed9bea51546bae
https://doi.org/10.1016/j.regpep.2013.03.023

Zobrazit plný text záznamu

Effect of glucagon-like peptide-2 exposure on bone resorption: Effectiveness of high concentration versus prolonged exposure

Autor: Palle Jeppesen, C. Askov-Hansen, Jens J. Holst, Dennis Bang Henriksen, Bolette Hartmann, P. Lund

Publikováno v: Regulatory Peptides. 181:4-8

Objective In healthy subjects, subcutaneous injections of GLP-2 have been shown to elicit dose-related decrease in the bone resorption marker, carboxy-terminal telopeptide of type I collagen (CTX), and have been proposed for the treatment of osteopor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::146a171768f88fc87d3c10569bb21792
https://doi.org/10.1016/j.regpep.2012.11.002

Zobrazit plný text záznamu

Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study

Autor: Palle Jeppesen, Bolette Hartmann, Christopher F. Brandt, Rahim M. Naimi, Jens J. Holst, P. B. Mortensen, C. Askov-Hansen, K.B. Madsen

Publikováno v: Regulatory peptides. 184

Background and aims The ileocolonic brake is impaired in short bowel syndrome (SBS) patients with distal bowel resections. An attenuated meal-stimulated hormone secretion may cause gastric hypersecretion, rapid gastric and intestinal transit and a po

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c773d0fdf02a2628fe088a903dfae8ed
https://pubmed.ncbi.nlm.nih.gov/23511332

Zobrazit plný text záznamu

Glucagon-like peptide-2 stimulates mucosal microcirculation measured by laser Doppler flowmetry in end-jejunostomy short bowel syndrome patients

Autor: Christopher F. Brandt, Palle Jeppesen, P. Høyerup, Per M. Hellström, Peter T. Schmidt, P. B. Mortensen, C. Askov-Hansen

Publikováno v: Regulatory peptides. 180

In animal and human studies glucagon-like peptide-2 (GLP-2) has been shown to increase blood flow in the superior mesenteric artery and the portal vein. This study describes the effect of GLP-2 measured directly on the intestinal mucosal blood flow b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dfb1f9eb6f7e2e815889cdc5e9f215d
https://pubmed.ncbi.nlm.nih.gov/23159451

Zobrazit plný text záznamu

PP175-SUN CONSEQUENCES OF CATHETER-RELATED INFECTIONS IN PATIENTS WITH INTESTINAL FAILURE. RESULTS EXTRACTED FROM THE WORLD LARGEST SINGLE CENTER DATABASE

Autor: Christopher F. Brandt, Per Brøbech, Lone Tjellesen, Michael Staun, Louise Bangsgaard, P. Bekker Jeppesen, Kent V. Haderslev, Klavs Holtug, C. Askov-Hansen

Publikováno v: Clinical Nutrition Supplements. 7:95

lead to a stabilisation or even an improvement of the bone mineral density (BMD) on the long range. Methods: Retrospective study of patients under HPN followed by the Gastroenterology Service of St-Luc Hospital from 2004 to 2011. Exclusion criteria w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::38b05e89ccb4f62158061885b84bffe6
https://doi.org/10.1016/s1744-1161(12)70226-0

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání